ALLR · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2025-08-15 compared with 2025-05-09 · 4 added, 3 removed, 49 unchanged (13% of the section changed)
Other Information.
−Removed: None of our directors or officers adopted or terminated a Rule 10b5 - 1 trading arrangement or a non-Rule 10b5 - 1 trading arrangement (as defined in Item 408 (c) of Regulation S-K) during the first quarter of 2025.
+Added: None of our directors or officers adopted or terminated a Rule 10b5 - 1 trading arrangement or a non-Rule 10b5 - 1 trading arrangement (as defined in Item 408 (c) of Regulation S-K) during the second quarter of 2025.
See the Exhibit Index to this Quarterly Report immediately below and before the signature page hereto, which Exhibit Index is incorporated by reference as if fully set forth herein.
41 unchanged sentences
ALLARITY THERAPEUTICS, INC.,
+Added: August 15, 2025
/s/ Thomas H.
1 unchanged sentence
(Principal Executive Officer)
−Removed: /s/ Alexander Epshinsky
−Removed: Alexander Epshinsky
+Added: August 15, 2025
+Added: /s/ Jeffrey S.
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.